Tagged with R

Italy Stevanato Group’s CEO & COO, Franco Moro explaines how the over 70-year-old provider of  containment and delivery solutions went public and as an established player in the vaccine space managed to service large pharmaceutical companies during the pandemic. He also speaks about the company’s move towards further internationalisation. … the…

South Korea Eutilex’s CEO, Byoung S. Kwon, outlines the company’s approach to cancer research, including its antibodies and CAR-T-centred pipeline and focus on unmet needs. He also explains recent partnerships in China.   … these different therapeutic platforms are based upon how we can handle these T-cells to attack cancer, and then…

Spain Spain is playing an important role in the production of COVID-19 vaccines with four Spanish companies involved in vaccine manufacturing projects, three of them doing fill and finish and one with an original vaccine candidate. Unfortunately, Spain’s vaccine manufacturers have faced quality control issues resulting in major recalls.   “The…

Turkey Turkey’s pharma market, the 18th largest in the world and valued at USD 7 Billion in 2020, has seen steady growth over the past few years due to favorable healthcare reforms and increased government support. According to a new report from Invest in Turkeye, in 2020 the country accounted for…

Global The COVID-19 pandemic brought the issue of access to medicines to the forefront. Not only did supply chain disruptions lead to initiatives designed to make sure essential medicines reach patients, but the pandemic also served to underline a number of pre-existing access inequalities. Several of PharmaBoardroom’s recent interviewees have discussed…

Italy Merck Italia’s Managing Director & President, Jan Kirsten explains the importance of the Italian affiliate within the global organisation, Merck’s aim to strengthen its position in oncology and the challenges of fertility in a country with one of the lowest birthrates in the world. [In Italy] we have the full…

Pharma Legal Handbook A brief overview of the situation regarding regulatory, pricing and reimbursement in Uruguay. Prepared in association with FERRERE, a leading law firm in Uruguay, this is an extract from The Pharma Legal Handbook: Uruguay, available to purchase here for USD 99.   1. What are the regulatory authorities with jurisdiction…

Pharma Legal Handbook Preclinical and clinical trial requirements in Uruguay –  a legal guide. Prepared in association with FERRERE, a leading law firm in Uruguay, this is an extract from The Pharma Legal Handbook: Uruguay, available to purchase here for USD 99.   1. Are clinical trials required to be conducted locally as…

Pharma Legal Handbook All about marketing, manufacturing, packaging & labeling and advertising in Uruguayan pharma. Prepared in association with FERRERE, a leading law firm in Uruguay, this is an extract from The Pharma Legal Handbook: Uruguay, available to purchase here for USD 99.   1. What is the authorization process for the marketing of new drugs,…

Pharma Legal Handbook The key facts about traditional medicines and OTC products in Uruguay. Prepared in association with FERRERE, a leading law firm in Uruguay, this is an extract from The Pharma Legal Handbook: Uruguay, available to purchase here for USD 99.   1. What are the regulatory requirements for traditional, herbal, complementary, or alternative…

Pharma Legal Handbook The legal framework for product liability in Uruguay. Prepared in association with FERRERE, a leading law firm in Uruguay, this is an extract from The Pharma Legal Handbook: Uruguay, available to purchase here for USD 99.   1. What types of liability are recognized in your jurisdiction? Product liability could be attributed…

Pharma Legal Handbook An insight into patents and trademarks in Uruguay. Prepared in association with FERRERE, a leading law firm in Uruguay, this is an extract from The Pharma Legal Handbook: Uruguay, available to purchase here for USD 99.   1. What are the basic requirements to obtain patent and trademark protection? For trademarks, the…